N-c(=x)x Containing (x Is Chalcogen) Doai Patents (Class 514/476)
  • Patent number: 6103768
    Abstract: The invention described here concerns the unique utility of fatty acids and their derivatives to eradicate existing fungal and bacterial infections in plants. Also, described herein are combination treatments whereby fatty acids are used to enhance or augment the activity of fungicides, bactericides, and biological control agents.
    Type: Grant
    Filed: September 8, 1997
    Date of Patent: August 15, 2000
    Assignee: Mycogen Corporation
    Inventors: Steven D. Savage, Steven L. Evans, Robert A. Haygood, Paul S. Zorner, Keith Jones
  • Patent number: 6075023
    Abstract: Fish mycoses and single-cell ectoparasites on fish are controlled using an active compound suitable for inhibiting the mitochondrial respiratory chain at the stage of the b/c.sub.1 complex.
    Type: Grant
    Filed: February 17, 1998
    Date of Patent: June 13, 2000
    Assignee: BASF Aktiengesellschaft
    Inventors: Gerhard Peter Dohmen, Christoph Kunast, Reinhart Munk, Gerhard Rothhaas
  • Patent number: 6057363
    Abstract: New active compound combinations of valinamide derivatives of the formula (I) ##STR1## in which R.sup.1 and R.sup.2 has the meaning given in the description,with known fungicidal active substances, and their use for combating phytopathogenic fungi are described.
    Type: Grant
    Filed: July 6, 1998
    Date of Patent: May 2, 2000
    Assignee: Bayer Aktiengesellschaft
    Inventors: Heinz-Wilhelm Dehne, Wilhelm Brandes, Karl-Heinz Kuck, Thomas Seitz
  • Patent number: 6030924
    Abstract: The novel solid formulations obtained by low pressure extrusion of a mixture comprisingat least one active ingredient; andat least one defoaming agent and/or foam breaking agent from thegroup consisting of perfluoroalkylphosphinic acids and/orperfluoroalkylphosphonic acids and/or their salts,show foam breaking activities even after extrusion, drying and storage at elevated temperatures and are thus very suitable for preparing tank mixtures for use in crop protection.
    Type: Grant
    Filed: May 1, 1998
    Date of Patent: February 29, 2000
    Assignee: American Cyanamid Company
    Inventors: Winfried Mayer, Christian Wassmer, Sandra Doerr
  • Patent number: 6020317
    Abstract: The object of the invention is to provide a lipid device functionally equivalent to the so-called cationic liposome and of lesser toxicity and a lipid or the like as a component of the device.The compound of the invention includes but is not limited to 3-O-(4-dimethylaminobutanoyl)-1,2-O-dioleylglycerol, 3-O-(2-dimethylaminoethyl)carbamoyl-1,2-O-dioleylglycerol, 3-O-(2-diethylaminoethyl) carbamoyl-1,2-O-dioleylglycerol and 2-O-(2-diethylaminoethyl) carbamoyl-1,3-O-dioleoylglycerol. The device of the invention comprises such a lipid and a phospholipid.By administering a double-stranded RNA, for instance, together with the device of the invention, the double-stranded RNA can be safely delivered to the site of action.
    Type: Grant
    Filed: October 23, 1995
    Date of Patent: February 1, 2000
    Assignee: Nippon Shinyaku Co. Ltd.
    Inventors: Yano Junichi, Tadaaki Ohgi
  • Patent number: 5989597
    Abstract: A process for continuously and instantaneously sterilizing soil comprising the steps of applying a water-activated chemical fumigant below the surface of the soil which simultaneously applying water to the soil below the surface. The soil, chemical fumigant and water are throughly mixed to cause instantaneous reaction of 100% of the chemical fumigant to produce a fumigant gas. Immediately covering the treated soil with a gas impervious material to retain the gas within the soil and kill the pathogens contained therein. Thereafter innoculating the soil with antgonistic organisms for preventing recontamination of the soil.
    Type: Grant
    Filed: December 26, 1995
    Date of Patent: November 23, 1999
    Inventor: Ambrose H. J. Rajamannan
  • Patent number: 5977147
    Abstract: Novel 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols, intermediates and processes for the preparation thereof, and methods of reducing inflammation and cell proliferation, and relieving memory dysfunction, and inhibiting bacterial and fungal growth are disclosed.
    Type: Grant
    Filed: April 24, 1996
    Date of Patent: November 2, 1999
    Assignee: Hoechst Marion Roussel
    Inventors: John Joseph Tegeler, Barbara Seavey Rauckman, Russell Richard Lee Hamer, Brian Scott Freed, Gregory Harold Merriman
  • Patent number: 5973000
    Abstract: The invention relates to a hair revitalizing tonic composition containing, as an active ingredient, at least one lipid derivative of the general formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4 and Y are as defined in the specification, and a and b are 0 or 1, as well as its use. Thus, there is provided a hair revitalizing tonic composition having an excellent hair loss prevention and hair revitalizing effect and, moreover, an excellent dandruff and itchy scalp prevention effect.
    Type: Grant
    Filed: June 3, 1997
    Date of Patent: October 26, 1999
    Assignees: Shiseido Company, Ltd., Takeda Chemical Industries, Ltd.
    Inventors: Tsunao Magara, Yoshiharu Tsuji, Chika Hamada, Yosuke Nakazawa, Eriko Takeoka, Masahiro Tajima, Masazumi Watanabe
  • Patent number: 5962518
    Abstract: There are described new active compound combinations of a compound of the formula (I) ##STR1## with known fungicidal active compounds, and their use for combating phytopathogenic fungi.
    Type: Grant
    Filed: October 1, 1997
    Date of Patent: October 5, 1999
    Assignee: Bayer Aktiengesellschaft
    Inventors: Klaus Stenzel, Wilhelm Brandes, Stefan Dutzmann, Bernd-Wieland Kruger, Karl-Heinz Kuck, Rolf Pontzen, Thomas Seitz, Atsumi Kamochi, Ikuya Saitoh
  • Patent number: 5958971
    Abstract: Prodrugs, of generic formula I, are disclosed for use in antibody directed enzyme prodrug therapy (ADEPT). The prodrugs are substrates for carboxypeptidase G2 (CPG2) and yield more active cytotoxic drugs than known products of CPG2 catalyzed reactions.
    Type: Grant
    Filed: October 22, 1997
    Date of Patent: September 28, 1999
    Assignees: Zeneca Limited, Cancer Research Campaign Technology Limited
    Inventors: Philip John Burke, Robert Ian Dowell, Anthony Brian Mauger, Caroline Joy Springer
  • Patent number: 5952386
    Abstract: The present invention provides dihalopropene compounds of the general formula: ##STR1## wherein R.sub.1 is C.sub.1 -C.sub.10 alkyl or the like; L is C(.dbd.O)NH or the like; R.sub.2, R.sub.3 and R.sub.4 are independently halogen or the like; R.sub.5, R.sub.6 and R.sub.7 are independently hydrogen or the like; m is an integer of 0 to 4; n is an integer of 0 to 2; X is chlorine or the like; Y is oxygen or the like; and Z is oxygen or the like, which have excellent insecticidal activity so that they are satisfactorily effective for the control of noxious insects.
    Type: Grant
    Filed: September 24, 1997
    Date of Patent: September 14, 1999
    Assignee: Sumitomo Chemical Company, Limited
    Inventors: Sanshiro Matsuo, Taro Hirose, Keiichi Izumi, Masaya Suzuki, Noriyasu Sakamoto, Kazunori Tsushima, Shigeru Saito, Hirotaka Takano
  • Patent number: 5939454
    Abstract: A fungicidal mixture comprisesa) an oxime ether carboxamide of the formula I ##STR1## where R is hydrogen or halogen andb) a dithiocarbamate (II) selected from the group consisting ofmanganese ethylenebis(dithiocarbamate) (zinc complex) (IIa),manganese ethylenebis(dithiocarbamate) (IIb),zinc ammoniate ethylenebis(dithiocarbamate) (IIc) andzinc ethylenebis(dithiocarbamate) (IId)in a synergistically active amount.
    Type: Grant
    Filed: January 20, 1998
    Date of Patent: August 17, 1999
    Assignee: BASF Akdtiengesellschaft
    Inventors: Barbara Schwalge, Ruth Muller, Herbert Bayer, Hubert Sauter, Eberhard Ammermann, Gisela Lorenz, Siegfried Strathmann
  • Patent number: 5922761
    Abstract: In accordance with the present invention, there are provided methods for the in vivo reduction of free iron ion levels in a mammalian subject. The present invention employs a scavenging approach whereby free iron ions are bound in vivo to a suitable physiologically compatible scavenger. The resulting complex renders the free iron ions harmless, and is eventually excreted in the urine of the host. Further in accordance with the present invention, there are provided compositions and formulations useful for carrying out the above-described methods. An exemplary scavenger contemplated for use in the practice of the present invention is a dithiocarbamate-containing composition. This material binds to free iron ions, forming a stable, water-soluble dithiocarbamate-iron complex.
    Type: Grant
    Filed: September 6, 1996
    Date of Patent: July 13, 1999
    Assignee: Medinox, Inc.
    Inventor: Ching-San Lai
  • Patent number: 5902828
    Abstract: A fungicidal mixture comprisinga) the oxime ether carboxylic ester of the formula I ##STR1## and b) a dithiocarbamate (II) selected from the group consisting ofmanganese ethylenebis(dithiocarbamate) (zinc complex) (IIa),manganese ethylenebis(dithiocarbamate) (IIb),zinc ammoniate ethylenebis(dithiocarbamate) (IIc) andzinc ethylenebis(dithiocarbamate) (IId)in a synergistically effective amount.
    Type: Grant
    Filed: December 4, 1996
    Date of Patent: May 11, 1999
    Inventor: Eberhard Ammermann
  • Patent number: 5891908
    Abstract: Fungicidal mixtures comprisinga) the oxime ether carboxylic ester of the formula I ##STR1## and b) 1-(2-cyano-2-methoxyiminoacetyl)-3-ethylurea (II)H.sub.3 CCH.sub.2 --NHCONH--C (CN).dbd.NOCH.sub.3 IIin a synergistically effective amount.
    Type: Grant
    Filed: December 10, 1996
    Date of Patent: April 6, 1999
    Assignee: BASF Aktiengesellschaft
    Inventors: Eberhard Ammermann, Gisela Lorenz, Dietrich Mappes, Klaus Schelberger, Manfred Hampel
  • Patent number: 5858402
    Abstract: In accordance with the present invention, there are provided in vivo methods for the reduction of cyanide levels. The present invention employs a scavenging approach whereby cyanide is bound in vivo to a suitable scavenger. The resulting complex renders the cyanide harmless, and is eventually excreted in the urine of the host. Further in accordance with the present invention, there are provided compositions and formulations useful for carrying out the above-described methods.
    Type: Grant
    Filed: February 11, 1997
    Date of Patent: January 12, 1999
    Assignee: Medinox, Inc.
    Inventor: Ching-San Lai
  • Patent number: 5856354
    Abstract: The invention concerns tachykinin antagonists. The compounds are neopeptides which have utility in treating disorders mediated by tachykinins. Such disorders are respiratory, inflammatory, gastrointestinal, ophthalmic, allergies, pain, vascular, diseases of the central nervous system, and migraine. Methods of preparing compounds and novel intermediates are also included. The compounds are expected to be especially useful in asthma and rheumatoid arthritis.
    Type: Grant
    Filed: October 17, 1997
    Date of Patent: January 5, 1999
    Assignee: Warner-Lambert Company
    Inventors: David Christopher Horwell, William Howson, Martyn Clive Pritchard, Edward Roberts, David Charles Rees
  • Patent number: 5846997
    Abstract: The present invention relates to water-emulsifiable liquid formulations of insecticidal active compounds, characterized in that they containa) 2.5 to 30% of active compound,b) 5 to 77.5% of a mixture of benzyl acetate and an alcohol in the ratio 25-95% to 5-75%,c) 2.5 to 20% of formulation auxiliary.
    Type: Grant
    Filed: April 29, 1996
    Date of Patent: December 8, 1998
    Assignee: Bayer Aktiengesellschaft
    Inventors: Kirkor Sirinyan, Rainer Sonneck, Klaus Mrusek
  • Patent number: 5814667
    Abstract: The present invention provides a method for sensitizing hypoxic cells in a tumor to radiation, wherein nitric oxide is delivered to target hypoxic cells through the administration of a nitric oxide-containing compound that spontaneously releases nitric oxide under physiological conditions without requiring the presence of oxygen. Also provided are methods of protecting noncancerous cells or tissues in a mammal from radiation, sensitizing cancerous cells in a mammal to chemotherapeutic agents, and protecting noncancerous cells or tissues in a mammal from chemotherapeutic agents, all by administration of the same compounds.
    Type: Grant
    Filed: March 11, 1997
    Date of Patent: September 29, 1998
    Assignee: United States of America as represented by the Department of Health and Human Services
    Inventors: James B. Mitchell, Angelo Russo, Murali C. Krishna, David A. Wink, Jr., James E. Liebmann
  • Patent number: 5811456
    Abstract: Novel monoamine oxidase B inhibitors of formula (I), wherein R.sub.1 .dbd.H, an optionally substituted benzyloxy or phenylethoxy group; p=0-3; R.sub.3 .dbd.H, a CN, OH, CCH group, a C.sub.1 -C.sub.3 alkoxy-carbonyl group, or a C.sub.1 -C.sub.3 alkylated cyanomethyl group; R.sub.2 .dbd.H or a C.sub.1 -C.sub.3 alkyl group; n=0 or 1; if n=0, R.sub.4 is a C.sub.1 -C.sub.3 alkyl group or a C.sub.1 -C.sub.3 alkoxy group, while if n=1, y=1 and R.sub.4 is a C.sub.1 -C.sub.3 alkyl group, a C.sub.1 -C.sub.3 alkoxy group or a phenyl group. The invention also concerns processes for the preparation of said novel inhibitors and the therapeutic use thereof.
    Type: Grant
    Filed: August 6, 1996
    Date of Patent: September 22, 1998
    Assignees: Laboratoires Mayoly Spindler, Michel Seman
    Inventors: Michel Seman, Suzanne Bernard, Rene Milcent, Catherine Paillat
  • Patent number: 5773014
    Abstract: Compositions for inhibiting the formation of unwanted skin pigmentation combine high tyrosinase blocking capabilities with stability in cosmetic preparations, absence of significant cytotoxic effects and synergy of action. The active components of the compositions include extracts of certain selected plants, namely, mulberry, saxifrage, grape and scutellaria root; and, preferably, ethylenediaminetetraacetic acid (EDTA). These ingredients are combined with various cosmetically acceptable carriers to produce cream and lotion formulations capable of whitening skin safely and effectively.
    Type: Grant
    Filed: October 7, 1996
    Date of Patent: June 30, 1998
    Assignee: Bioetica, Inc.
    Inventors: Eric Perrier, Delphine Rival
  • Patent number: 5763480
    Abstract: The present invention provides a method for blocking a cellular proton pump that comprises contacting a cell with a cellular proton pump-blocking effective quantity of In-EDTA or Tl-EDTA. The present invention also provides a method of treating or preventing cell-mediated disorders in a vertebrate animal by administering In-EDTA or Tl-EDTA to the vertebrate animal, as well as a method for stopping the cellular proton pump-blocking effect of Group IIIa metals such as Ga, In, and Tl, through use of suitable chelating agents. Suitable compositions for use in the aforementioned methods are provided as well.
    Type: Grant
    Filed: February 14, 1994
    Date of Patent: June 9, 1998
    Assignee: The Jewish Hospital of St. Louis
    Inventors: Paul H. Schlesinger, Steven L. Teitelbaum, Harry C. Blair
  • Patent number: 5677333
    Abstract: A method for controlling phytopathogenic fungi comprises applying a selected fungicidally active N-acetonylbenzamide compound and a second fungicidally active compound selected from the group consisting of manganese-zinc ethylenebis(dithiocarbamate), manganese ethylenebis(dithiocarbamate), zinc ammoniate ethylenebis(dithiocarbamate), zinc ethylenebis(dithiocarbamate), 2-cyano-N-((ethylamino)carbonyl)-2-(methoxyimino)acetamide, and (E,Z) 4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholine to plant seed, to plant foliage or to a plant growth medium and provides higher fungicidal activity than separate use of the same compounds.
    Type: Grant
    Filed: July 8, 1996
    Date of Patent: October 14, 1997
    Assignee: Rohm and Haas Company
    Inventors: Daniel Louis Loughner, Enrique Luis Michelotti, Willie Joe Wilson, David Hamilton Young
  • Patent number: 5665770
    Abstract: The invention provides a method for treatment of cataract which comprises administering to a subject in need of such treatment, a radical scavenger in an amount effective in treatment of cataract selected from the group consisting of a reducing thiol derivative, or a disulfide derivative and a sulfide derivative thereof, and a pharmaceutical composition for treatment of cataract which comprises an anti-cataract agent containing a radical scavenger and fine particles, such as emulsions, nanocapsules, alubmin microspheres and liposomes, which carries an anti-cataract agent and has a lipophilic and positively charged phase on the surface thereof.
    Type: Grant
    Filed: November 3, 1994
    Date of Patent: September 9, 1997
    Assignee: Gakko Hojin Kinki Daigaku
    Inventors: Motome Terao, Yoshimasa Ito
  • Patent number: 5660829
    Abstract: Prodrugs, of generic formula I, are disclosed for use in antibody directed enzyme prodrug therapy (ADEPT). The prodrugs are substrates for carboxypeptidase G2 (CPG2) and yield more active cytotoxic drugs than known products of CPG2 catalysed reactions.
    Type: Grant
    Filed: May 16, 1995
    Date of Patent: August 26, 1997
    Assignees: Zeneca Limited, Cancer Research Campaign Technology
    Inventors: Philip John Burke, Robert Ian Dowell, Anthony Brian Mauger
  • Patent number: 5656615
    Abstract: This invention is a pharmaceutical composition that inhibits the growth of cancers and tumors in mammals, particularly in human and warm blooded animals. The composition contains a 10:1 to 1:10 mixture of (1) N-chlorophenyl carbamates and N-chlorophenylthiocarbamates and (2) N-phosphonoglycine derivatives which are systemic herbicides. This composition can also be used to treat viral infections.
    Type: Grant
    Filed: April 12, 1995
    Date of Patent: August 12, 1997
    Assignee: The Procter & Gamble Company
    Inventor: James Berger Camden
  • Patent number: 5646157
    Abstract: The present invention relates to a process of disposing obsolete planting seed treated with seed-protectant coatings, especially coatings comprising captan or any of the other widely used compounds such as, for example, pirimiphos-methyl and thiram, alone or in combination with other fungicidally or even insecticidally active compounds, which process comprises subjecting the said plant seed to a compostation.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: July 8, 1997
    Assignee: Novartis Corporation
    Inventor: Kaspar J. Hohl
  • Patent number: 5643945
    Abstract: Ingestible compounds which are substantially tasteless and which have been found to be effective reducers or eliminators of undesirable tastes for eatables.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: July 1, 1997
    Assignee: Bioresearch, Inc.
    Inventors: Robert J. Kurtz, William D. Fuller
  • Patent number: 5643946
    Abstract: Compounds of the formula ##STR1## wherein the substituents are as defined herein, are disclosed. Pharmaceutical compositions and methods of treating allergic and inflammatory diseases are also taught.
    Type: Grant
    Filed: May 18, 1995
    Date of Patent: July 1, 1997
    Assignee: SmithKline Beecham Corporation
    Inventor: Siegfried Benjamin Christensen, IV
  • Patent number: 5633254
    Abstract: Synergistic mixtures which include dimethomorph and cymoxonil in a fungicidially effective aggregate amount, and the use of such mixtures in the control of plant diseases. In certain embodiments, a contact fungicide is included, along with the dimethomorph and cymoxonil in suitable ratios.
    Type: Grant
    Filed: January 11, 1996
    Date of Patent: May 27, 1997
    Assignees: Agrogene Ltd., C.T.S. Ltd.
    Inventor: Yigal Cohen
  • Patent number: 5629341
    Abstract: This invention is a pharmaceutical composition that inhibits the growth of cancers and tumors in mammals, particularly in human and warm blooded animals. The composition is also effective against viruses. The composition contains N-chlorophenylcarbamates and N-chlorophenylthiocarbamates which are systemic herbicides.
    Type: Grant
    Filed: April 12, 1995
    Date of Patent: May 13, 1997
    Assignee: The Procter & Gamble Company
    Inventor: James B. Camden
  • Patent number: 5626883
    Abstract: A vitamin C supplement comprising ascorbic acid, ascorbyl palmitate, niacinamide ascorbate, calcium ascorbate, magnesium ascorbate, potassium ascorbate, and sodium ascorbate which together can be administered to a human to avoid the transitory initial suppression of human NK cell activity which is present when ascorbic acid alone is administered. Also included is xylitol, lysine acetate, tetrasodium pyrophosphate, ribose, cysteine, and hesperidin which further prolongs the biological activity of ascorbic acid and promotes the uptake of ascorbic acid by human tissue.
    Type: Grant
    Filed: April 15, 1994
    Date of Patent: May 6, 1997
    Assignee: Metagenics, Inc.
    Inventor: Stephen M. Paul
  • Patent number: 5607980
    Abstract: The compositions of the present invention are useful for topical application to human skin. These compositions provide improved skin feel. These compositions can be in the form of leave-on products or products that are rinsed or wiped from the skin after use. These compositions are also useful for conditioning desquamating, and cleansing the skin and for relieving dry skin.
    Type: Grant
    Filed: July 24, 1995
    Date of Patent: March 4, 1997
    Assignee: The Procter & Gamble Company
    Inventors: David M. McAtee, Lourdes D. Albacarys, Erik J. Hasenoehrl, Joseph A. Listro
  • Patent number: 5583089
    Abstract: This invention provides a dry blend pesticide composition which contains a fungicidal bicarbonate salt ingredient, and a spreader-sticker ingredient which is a crystalline clathrate complex of a urea constituent and a normally liquid spreader sticker constituent such as a nonionic surfactant. In a preferred embodiment all of the composition ingredients are water-soluble, and the composition is readily dispersible in an aqueous medium to form a sprayable pesticide solution.
    Type: Grant
    Filed: May 9, 1995
    Date of Patent: December 10, 1996
    Assignee: Church & Dwight Co., Inc.
    Inventor: Anthony E. Winston
  • Patent number: 5556880
    Abstract: The invention provides fungicidal combinations comprising:(a) a compound of formula A ##STR1## wherein each of R.sub.1 and R.sub.2, which are identical or different, is H, Hal or optionally halogenated lower alkyl, and each of R.sub.3 and R.sub.4, which are identical or different, is (C.sub.1 -C.sub.4) alkyl, and(b) at least one compound B selected from the group consisting of maneb, mancozeb, folpet, a copper derivative, phosethyl-Al or phosphorous acid or one of its alkali metal or alkaline-earth metal salts, chlorothalonil, fluazinam, an acylalanine, an acetamide, a methoxyacrylate or a methoxyiminoacetate.Fungicidal compositions comprising the combination and methods for curatively and preventatively treating plants against fungal disease are also provided.
    Type: Grant
    Filed: October 14, 1994
    Date of Patent: September 17, 1996
    Assignee: Rhone-Poulenc Agrocimie
    Inventor: Marie-Pascale Latorse
  • Patent number: 5550100
    Abstract: New and improved compositions comprising particulates and an effective amount of manganese chloride to reduce significantly the wetting time and/or the dispersion time of said particulates relative to said time(s) in the absence of said salt(s) have been discovered. Methods for reducing the wetting time of particulates in liquid have also been discovered.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: August 27, 1996
    Assignee: Rohm and Haas Company
    Inventor: Yili Guo
  • Patent number: 5519062
    Abstract: Novel 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols, intermediates and processes for the preparation thereof, and methods of reducing inflammation and cell proliferation, and relieving memory dysfunction, and inhibiting bacterial and fungal growth are disclosed.
    Type: Grant
    Filed: May 23, 1994
    Date of Patent: May 21, 1996
    Assignee: Hoechst-Roussel Pharmaceuticals Inc.
    Inventors: John J. Tegeler, Barbara S. Rauckman, Russell R. L. Hamer, Brian S. Freed, Gregory H. Merriman
  • Patent number: 5516748
    Abstract: New and improved compositions comprising particulates and an effective amount of one or more effective salt(s) to reduce significantly the wetting time and/or the dispersion time of said particulates relative to said time(s) in the absence of said salt(s) have been discovered. Methods for reducing the wetting time of particulates in liquid have also been discovered.
    Type: Grant
    Filed: April 12, 1995
    Date of Patent: May 14, 1996
    Assignee: Rohm and Haas Company
    Inventor: Yili Guo
  • Patent number: 5504109
    Abstract: Amino-acid derivatives of the formula ##STR1## in which R.sup.1 represents alkyl, alkenyl, alkinyl, halogenoalkyl, halogenoalkenyl, halogenoalkinyl, cycloalkyl, cycloalkenyl, unsubstituted or substituted aryl, unsubstituted or substituted aralkyl, unsubstituted or substituted heteroaryl, and unsubstituted or substituted heteroarylalkyl,R.sup.2, R.sup.5 are identical or different and represent hydrogen or lower alkyl,R.sup.3, R.sup.4 represent hydrogen, cycloalkyl or alkyl, orR.sup.3 and R.sup.4, together with the carbon atom to which they are bonded, form a cycloalkyl ring,R.sup.6 represents unsubstituted or substituted straight-chain or branched cycloalkylalkyl, unsubstituted or substituted straight-chain or branched cycloalkenyl, alkyl, or alkyl-bridged cycloalkylalkyl.The compounds are useful as pesticidal agents.
    Type: Grant
    Filed: November 13, 1992
    Date of Patent: April 2, 1996
    Assignee: Bayer Aktiengesellschaft
    Inventors: Thomas Seitz, Heinz-Wilhelm Dehne
  • Patent number: 5470586
    Abstract: A method of controlling the attachment of organisms to an underwater surface is disclosed. The method comprises contacting the organisms with a compound of Formula I ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are each independently hydrogen, C.sub.1 -C.sub.3 alkyl, C.sub.1 -C.sub.3 alkoxy, halogen, or hydroxyl. Antifouling coatings and cementitious compositions containing a compound of Formula I are also disclosed.
    Type: Grant
    Filed: April 11, 1994
    Date of Patent: November 28, 1995
    Assignee: Duke University
    Inventor: Donald J. Gerhart
  • Patent number: 5432148
    Abstract: This invention provides a fungicide composition which is capable of in situ generation of ammonium bicarbonate when applied to plant foliage in the form of an aqueous dispersion. The constituents include (1) an ingredient such as urea which slow-releases ammonia under aqueous alkaline pH conditions; and (2) an alkali metal bicarbonate ingredient which imparts alkalinity to the aqueous dispersion, and provides bicarbonate ions for combination with the released ammonium ions. A spreader-sticker ingredient is included to maintain the ingredients in contact with plant foliage over an extended period after application.
    Type: Grant
    Filed: December 7, 1994
    Date of Patent: July 11, 1995
    Assignee: Church & Dwight Co., Inc.
    Inventor: Anthony E. Winston
  • Patent number: 5425952
    Abstract: This invention provides a fungicide composition which is capable of in situ generation of ammonium bicarbonate when applied to plant foliage in the form of an aqueous dispersion. The constituents include (1) an ingredient such as urea which slow-releases ammonia under aqueous alkaline pH conditions; and (2) an alkali metal bicarbonate ingredient which imparts alkalinity to the aqueous dispersion, and provides bicarbonate ions for combination with the released ammonium ions. A spreader-sticker ingredient is included to maintain the ingredients in contact with plant foliage over an extended period after application.
    Type: Grant
    Filed: October 13, 1993
    Date of Patent: June 20, 1995
    Assignee: Church & Dwight Co., Inc.
    Inventor: Anthony E. Winston
  • Patent number: 5411991
    Abstract: A method of reducing the rate of mammalian hair growth includes topically applying a composition containing a sulfhydryl reactive compound to the skin.
    Type: Grant
    Filed: December 22, 1992
    Date of Patent: May 2, 1995
    Inventors: Douglas Shander, Gurpreet S. Ahluwalia, Diana M-D. Grosso
  • Patent number: 5389674
    Abstract: Novel and improved fungicidal dithiocarbamate particulate compositions comprising one or more components selected from dithiocarbamates and bisdithiocarbamoyl disulfides and an effective amount of moisture content to significantly enhance the flowability of the particulate composition, reduce the dustiness of the composition, increase the bulk density of the composition and/or reduce the ethylenethiourea content of the composition. Methods for producing such particulate compositions are presented wherein controlled slurry production and spray-drying are effective in producing such compositions.
    Type: Grant
    Filed: July 12, 1993
    Date of Patent: February 14, 1995
    Assignee: Rohm and Haas Company
    Inventor: Yili Guo
  • Patent number: 5380747
    Abstract: Dithiocarboxylates, and in particular, dithiocarbamates, block the induced expression of the endothelial cell surface adhesion molecule VCAM-1, and are therefor useful in the treatment of cardiovascular disease, including atherosclerosis, post-angioplasty restenosis, coronary artery diseases, and angina, as well as noncardiovascular inflammatory diseases that are mediated by VCAM-1.
    Type: Grant
    Filed: October 30, 1992
    Date of Patent: January 10, 1995
    Assignee: Emory University
    Inventors: Russell M. Medford, Margaret K. Offermann, R. Wayne Alexander
  • Patent number: 5362748
    Abstract: The subject invention relates to methods for regulating hair growth in mammalian skin comprising topical application of diethyldithiocarbamic acid ("DEDCA") or a pharmaceutically-acceptable salt thereof. The subject invention further involves topical compositions comprising DEDCA.
    Type: Grant
    Filed: September 15, 1993
    Date of Patent: November 8, 1994
    Assignee: The Procter & Gamble Company
    Inventors: Richard J. Schwen, Donald L. Bissett
  • Patent number: 5294430
    Abstract: A process for preventing or ameliorating the myelosuppression which can occur in a mammal such as a human cancer patient being treated with a platinum-free antineoplastic drug is provided, comprising administering an effective dosage of a dithiocarbamate compound to said mammal, preferably subsequent to administration of the cytotoxic drug.
    Type: Grant
    Filed: July 30, 1992
    Date of Patent: March 15, 1994
    Assignee: University of Rochester
    Inventors: Richard F. Borch, Therese K. Schmalbach
  • Patent number: 5246954
    Abstract: The present invention relates to a process for the control of fungal disease of plants by applying to the leaves of the plants:a) 2-(4-chlorobenzylidene)-5,5-diemethyl-1-(1H-1,2,4-triazol-1-ylmethyl)-1-cy clopentanol;b) one or more fungicides suitable for protecting against the said fungal diseases and to compositions which may be used in the process.
    Type: Grant
    Filed: June 13, 1991
    Date of Patent: September 21, 1993
    Assignee: Rhone-Poulenc Secteur Agrochimie
    Inventors: Alfred Greiner, Jean Hutt, Jacques Mugnier, Regis Pepin
  • Patent number: 5198012
    Abstract: A biocide composition comprises an effective amount of a biocide and an effective amount of a biocide activator selected from the group consisting of an alkyl phosphate, an alkenyl phosphate, a hydroxyalkyl phosphate, a polyoxyalkylene alkyl ether phosphate, a salt thereof, a polyoxyalkylene alkenyl ether phosphate, a salt thereof, a polyoxyalkylene hydroxyalkyl ether phosphate and a salt thereof.
    Type: Grant
    Filed: May 21, 1991
    Date of Patent: March 30, 1993
    Assignee: Kao Corporation
    Inventor: Tetsuji Iwasaki
  • Patent number: 5187193
    Abstract: A process is provided for obtaining one or more bone marrow cell growth factors having granulocyte/macrophage progenitor cell colony stimulating activity, said process comprising: (a) adding to the culture medium of an in vitro, established bone marrow culture a growth factor-stimulating amount of a dithiocarbamate; (b) separating the said dithiocarbamate from the in vitro treated bone marrow culture, adding fresh culture medium to said in vitro treated bone marrow culture, and permitting the concentration of said growth factor or factors to increase in said fresh culture medium; and (c) isolating said growth factor or factors from said fresh culture medium.
    Type: Grant
    Filed: March 21, 1991
    Date of Patent: February 16, 1993
    Assignee: University of Rochester
    Inventors: Richard F. Borch, Therese K. Schmalbach